Pharma

Sun Pharma Invests in New Facility Amid FDA Challenges
Manufacturing Sun Pharma Invests in New Facility Amid FDA Challenges

What does it take for a pharmaceutical titan to pour $332 million into a new facility while staring down the barrel of regulatory scrutiny? Sun Pharma, India’s leading drugmaker, is capturing attention with a daring investment in Madhya Pradesh, India, even as it wrestles with significant

Novartis Bets $23B on Advanced Automated U.S. Manufacturing
Manufacturing Novartis Bets $23B on Advanced Automated U.S. Manufacturing

From Legacy Pills to Precision Platforms: Why Novartis Is Rewiring Its Factories Now A sprawling pivot only makes sense when the old playbook stops working and the new one promises faster launches, steadier supply, and tighter quality for therapies that cannot afford a slip. Manufacturing leaders

Almac Group Expands Singapore Facility with Major Investment
Manufacturing Almac Group Expands Singapore Facility with Major Investment

In a world where life-saving drugs race against time to reach patients, the backbone of pharmaceutical innovation often lies in the unseen logistics of clinical trials, especially in a region like Asia-Pacific, buzzing with research activity yet grappling with the challenge of managing complex

U-Trough Feeder Technology – Review
Manufacturing U-Trough Feeder Technology – Review

In the fast-paced world of industrial material handling, where efficiency can make or break production timelines, U-Trough Feeder technology stands as a cornerstone for managing dry bulk materials. Picture a bustling food processing plant, where every gram of flour or sugar must flow seamlessly to

Trump’s Tariff Threats Reshape Big Pharma in the U.S.
Manufacturing Trump’s Tariff Threats Reshape Big Pharma in the U.S.

In a landscape where the cost of prescription drugs continues to burden American households, President Trump’s aggressive tariff threats have emerged as a powerful tool to reshape the pharmaceutical industry, sparking intense debate. With millions of patients grappling with skyrocketing prices, the

How Will CSL’s $1.5B Boost U.S. Plasma Therapy Supply?
Manufacturing How Will CSL’s $1.5B Boost U.S. Plasma Therapy Supply?

As we dive into the world of biopharmaceuticals, I'm thrilled to sit down with Kwame Zaire, a renowned manufacturing expert with a deep focus on production management and innovation in the health industry. With his expertise in electronics, equipment, and predictive maintenance, Kwame offers a

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later